| Proteasome |
2.39 |
0.00e+0 |
44/46 (95.65%) |
PSMD2;PSMC2;PSMC1;...
|
| Protein processing in endoplasmic reticulum |
2.32 |
0.00e+0 |
127/171 (74.27%) |
HSPA6;HSPH1;HSPA8;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
2.14 |
0.00e+0 |
62/70 (88.57%) |
CXCL8;ATP6V0E1;RELA;...
|
| Parkinson disease |
2.13 |
0.00e+0 |
176/249 (70.68%) |
UCHL1;DDIT3;PSMD2;...
|
| Phagosome |
2.06 |
2.29e-3 |
118/152 (77.63%) |
TUBB2A;TAP1;HLA-DQA1;...
|
| Epstein-Barr virus infection |
2.06 |
1.91e-3 |
189/202 (93.56%) |
CDKN1A;PSMD2;PSMC2;...
|
| Collecting duct acid secretion |
2.06 |
1.64e-3 |
22/27 (81.48%) |
ATP6V0E1;SLC12A7;TCIRG1;...
|
| Herpes simplex virus 1 infection |
2.05 |
1.43e-3 |
165/498 (33.13%) |
TAP1;HLA-DQA1;RELA;...
|
| IL-17 signaling pathway |
2.04 |
1.27e-3 |
84/94 (89.36%) |
CXCL8;CEBPB;HSP90AA1;...
|
| Antigen processing and presentation |
2.00 |
1.15e-3 |
60/78 (76.92%) |
HSPA6;HSPA8;HSPA1A;...
|
| Prion disease |
1.99 |
1.04e-3 |
209/273 (76.56%) |
HSPA6;HSPA8;HSPA1A;...
|
| Legionellosis |
1.98 |
1.91e-3 |
51/57 (89.47%) |
HSPD1;HSPA6;HSPA8;...
|
| Ferroptosis |
1.94 |
4.41e-3 |
36/41 (87.8%) |
HMOX1;SLC7A11;GCLM;...
|
| Amyotrophic lateral sclerosis |
1.92 |
4.09e-3 |
267/364 (73.35%) |
SQSTM1;DDIT3;PSMD2;...
|
| Measles |
1.92 |
3.82e-3 |
133/139 (95.68%) |
HSPA6;HSPA8;HSPA1A;...
|
| Alzheimer disease |
1.90 |
3.58e-3 |
279/369 (75.61%) |
DDIT3;PSMD2;DKK1;...
|
| Apoptosis |
1.90 |
3.37e-3 |
126/168 (75%) |
DDIT3;CTSK;RELA;...
|
| Autophagy |
1.90 |
3.18e-3 |
113/169 (66.86%) |
SQSTM1;DDIT4;GABARAPL1;...
|
| Hepatitis C |
1.90 |
3.02e-3 |
139/157 (88.54%) |
CDKN1A;RELA;CXCL10;...
|
| Toll-like receptor signaling pathway |
1.86 |
3.44e-3 |
94/104 (90.38%) |
CXCL8;SPP1;CTSK;...
|
| Pathways of neurodegeneration |
1.86 |
3.28e-3 |
354/475 (74.53%) |
UCHL1;SQSTM1;DDIT3;...
|
| Lipid and atherosclerosis |
1.86 |
3.13e-3 |
190/215 (88.37%) |
HSPD1;HSPA6;HSPA8;...
|
| TNF signaling pathway |
1.82 |
4.98e-3 |
103/112 (91.96%) |
CEBPB;RELA;DNM1L;...
|
| Human papillomavirus infection |
1.81 |
4.78e-3 |
284/331 (85.8%) |
SPP1;CDKN1A;GNAS;...
|
| Mitophagy |
1.79 |
5.96e-3 |
56/68 (82.35%) |
SQSTM1;RELA;GABARAPL1;...
|
| Spinocerebellar ataxia |
1.79 |
5.73e-3 |
128/143 (89.51%) |
PSMD2;PSMC2;PSMC1;...
|
| Salmonella infection |
1.77 |
6.37e-3 |
198/249 (79.52%) |
CXCL8;HSP90AA1;HSP90AB1;...
|
| Staphylococcus aureus infection |
1.76 |
6.96e-3 |
72/95 (75.79%) |
KRT14;KRT17;KRT13;...
|
| Estrogen signaling pathway |
1.74 |
7.51e-3 |
119/137 (86.86%) |
HSPA6;HSPA8;KRT14;...
|
| Inflammatory bowel disease |
1.73 |
9.55e-3 |
58/65 (89.23%) |
HLA-DQA1;RELA;STAT4;...
|
| Valine, leucine and isoleucine degradation |
-1.66 |
4.93e-2 |
42/48 (87.5%) |
ACADSB;OXCT1;HMGCL;...
|
| Mismatch repair |
-1.68 |
4.66e-2 |
22/23 (95.65%) |
POLD4;RFC3;SSBP1;...
|
| Morphine addiction |
-1.69 |
4.43e-2 |
80/91 (87.91%) |
GNB1;PDE4D;GABRD;...
|
| Dilated cardiomyopathy |
-1.70 |
4.25e-2 |
86/96 (89.58%) |
MYL2;ITGA2;IGF1;...
|
| Fat digestion and absorption |
-1.73 |
2.93e-2 |
35/43 (81.4%) |
MTTP;APOA4;PLPP3;...
|
| Synthesis and degradation of ketone bodies |
-1.73 |
3.35e-2 |
9/10 (90%) |
OXCT1;BDH2;HMGCL;...
|
| Drug metabolism |
-1.73 |
3.91e-2 |
78/151 (51.66%) |
ADH1B;TK2;ADH6;...
|
| Fanconi anemia pathway |
-1.79 |
2.61e-2 |
36/54 (66.67%) |
TELO2;RAD51C;BRCA1;...
|
| Sulfur metabolism |
-1.82 |
2.82e-2 |
9/10 (90%) |
TST;PAPSS2;MPST;...
|
| Purine metabolism |
-1.82 |
3.48e-2 |
102/129 (79.07%) |
ENPP4;GART;NT5C2;...
|
| Butanoate metabolism |
-1.86 |
3.04e-2 |
23/28 (82.14%) |
OXCT1;L2HGDH;BDH2;...
|
| DNA replication |
-2.28 |
0.00e+0 |
34/36 (94.44%) |
RFC5;MCM6;MCM3;...
|
